Skip to content

In the BioHarmony Drug Report Database

Axicabtagene ciloleucel

Yescarta (axicabtagene ciloleucel) is a gene pharmaceutical. Axicabtagene ciloleucel was first approved as Yescarta on 2017-10-18. It has been approved in Europe to treat follicular lymphoma and large b-cell lymphoma diffuse.
Trade Name Yescarta
Common Name Axicabtagene ciloleucel
Indication follicular lymphoma, large b-cell lymphoma diffuse
Drug Class
Axicabtagene ciloleucel
Get full access now